Personal information

No personal information available

Activities

Collapse all

Employment (2)

University of the Witwatersrand: Johannesburg-Braamfontein, Gauteng, ZA

2019-07-01 to present | Lecturer (Family Medicine and Primary Care)
Employment
Source: Self-asserted source
Azwidihwi Takalani

Fred Hutchinson Cancer Research Centre: Seattle, Washington , US

2018-07-01 to present | Protocol Team Lead (HIV Vaccines Trial Network )
Employment
Source: Self-asserted source
Azwidihwi Takalani

Education and qualifications (3)

College of Medicine South Africa : Cape Town , Western Cape , ZA

2015-05-31 to present | Fellow (Public Health Medicine)
Qualification
Source: Self-asserted source
Azwidihwi Takalani

University of the Witwatersrand: Johannesburg-Braamfontein, Gauteng, ZA

2011-08-01 to 2015-07-31 | Resident (School of Public Health )
Qualification
Source: Self-asserted source
Azwidihwi Takalani

University of Cape Town: Cape Town , Western Cape , ZA

2001-01-01 to 2007-12-31 | medical student (Faculty of Health Sciences)
Qualification
Source: Self-asserted source
Azwidihwi Takalani

Works (9)

Vaccine pharmacovigilance in South Africa: successes and limitations of current approaches

Expert Opinion on Drug Safety
2024-10-02 | Journal article
DOI: 10.1080/14740338.2024.2387322
Part of ISSN: 1474-0338
Part of ISSN: 1744-764X
Contributors: J. Peter; A. Takalani; J. C. Meyer; B. Semete-Makokotlela; S. Collie; I. Seocharan; A. Goga; N. Garrett; L. Gail-Bekker; G. Gray
Source: Self-asserted source
Azwidihwi Takalani

Safety of a second homologous Ad26.COV2.S vaccine among healthcare workers in the phase 3b implementation Sisonke study in South Africa

Vaccine
2024-02 | Journal article
DOI: 10.1016/j.vaccine.2024.01.066
Contributors: Azwidihwi Takalani; Michelle Robinson; Phumeza Jonas; Annie Bodenstein; Vuyelo Sambo; Barry Jacobson; Vernon Louw; Jessica Opie; Jonny Peter; Pradeep Rowji et al.
Source: check_circle
Crossref

Allergic reactions to the Ad26.COV2.S Vaccine in South Africa

2024-01-31 | Preprint
DOI: 10.22541/au.170668816.68864620/v1
Contributors: Jonny PETER; Cascia Day; Simbarashe Takuva; Azwidihwi Takalani; Imke Engelbrecht; Nigel Garrett; Ameena Goga; Vernon Louw; Jessica Opie; Barry Jacobson et al.
Source: Self-asserted source
Azwidihwi Takalani

Vascular thrombosis after single dose Ad26.COV2.S vaccine in healthcare workers in South Africa: open label, single arm, phase 3B study (Sisonke study)

BMJ Medicine
2023-03 | Journal article
DOI: 10.1136/bmjmed-2022-000302
Part of ISSN: 2754-0413
Contributors: Barry Frank Jacobson; Elise Schapkaitz; Azwi Takalani; Pradeep Rowji; Vernon Johan Louw; Jessica Opie; Linda-Gail Bekker; Nigel Garrett; Ameena Goga; Tarylee Reddy et al.
Source: Self-asserted source
Azwidihwi Takalani

Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa

The Lancet
2022-07 | Journal article
DOI: 10.1016/s0140-6736(22)01190-4
Part of ISSN: 0140-6736
Contributors: Ameena Goga; Linda-Gail Bekker; Nigel Garrett; Tarylee Reddy; Nonhlanhla Yende-Zuma; Lara Fairall; Harry Moultrie; Azwidihwi Takalani; Valentina Trivella; Mark Faesen et al.
Source: Self-asserted source
Azwidihwi Takalani

Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial

PLOS Medicine
2022-06-21 | Journal article
DOI: 10.1371/journal.pmed.1004024
Contributors: Simbarashe Takuva; Amitabh Bipin Suthar; Azwidhwi Takalani; Ishen Seocharan; Nonhlanhla Yende-Zuma; Tarylee Reddy; Imke Engelbrecht; Mark Faesen; Kentse Khuto; Carmen Whyte et al.
Source: check_circle
Crossref

Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study

The Lancet
2022-03 | Journal article
DOI: 10.1016/s0140-6736(22)00007-1
Part of ISSN: 0140-6736
Contributors: Linda-Gail Bekker; Nigel Garrett; Ameena Goga; Lara Fairall; Tarylee Reddy; Nonhlanhla Yende-Zuma; Reshma Kassanjee; Shirley Collie; Ian Sanne; Andrew Boulle et al.
Source: Self-asserted source
Azwidihwi Takalani
grade
Preferred source (of 2)‎

Breakthrough Covid-19 infections during periods of circulating Beta, Delta and Omicron variants of concern, among health care workers in the Sisonke Ad26.COV2.S vaccine trial, South Africa

2021-12-21 | Preprint
DOI: 10.1101/2021.12.21.21268171
Contributors: Ameena Goga; Linda-Gail Bekker; Nigel Garrett; Tarylee Reddy; Nonhlanhla Yende-Zuma; Lara Fairall; Harry Moultrie; Azwidihwi Takalani; Valentina Trivella; Mark Faesen et al.
Source: Self-asserted source
Azwidihwi Takalani

Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study

New England Journal of Medicine
2021-06-02 | Journal article
DOI: 10.1056/nejmc2107920
Part of ISSN: 0028-4793
Part of ISSN: 1533-4406
Contributors: Simbarashe Takuva; Azwidhwi Takalani; Nigel Garrett; Ameena Goga; Jonny Peter; Vernon Louw; Jessica Opie; Barry Jacobson; Ian Sanne; Linda Gail-Bekker et al.
Source: Self-asserted source
Azwidihwi Takalani
How many people are using ORCID?